ΒΙΟΓΡΑΦΙΚΟ ΣΗΜΕΙΩΜΑ ΟΝΟΜΑ ΕΠΩΝΥΜΟ Ειρήνη Παντερή ΗΜΕΡΟΜΗΝΙΑ 16/01/1967 ΤΗΛΕΦΩΝΟ 210 72 74 820 e-mail ipanderi@pharm.uoa.gr ΕΚΠΑΙΔΕΥΣΗ: 1985-1989 Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών, Τμήμα Φαρμακευτικής. Πτυχίο Φαρμακοποιού 1990 Αδειούχος Φαρμακοποιός ΚΕ.Σ.Υ 1990-1994 Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών, Τμήμα Φαρμακευτικής, Τομέας Φαρμακευτικής Χημείας. Διδακτορικό Δίπλωμα. 2004 Πιστοποιητικό επιθεωρητή συστημάτων ποιότητας κατά τη σειρά προτύπων ISO 9000: 2000 από το Διεθνές Μητρώο Πιστοποιημένων επιθεωρητών. (Certificate of Auditor / Lead Auditor, International Register of Certificate Auditors, London UK). ΜΕΤΕΚΠΑΙΔΕΥΣΗ: Μετεκπαίδευση σε μελέτες πρωτεομίων με nanolc-esi-fticr-ms: Τομέας Μοριακής Βιομετρίας του Ινστιτούτου Κυτταρικής και Μοριακής Βιολογίας, του Πανεπιστημίου της Ουψάλα στη Σουηδία. (Institute for Cell and Molecular Biology, Division of Molecular Biometry), Οκτώβριος-Νοέμβριος 2007 ΞΕΝΕΣ ΓΛΩΣΣΕΣ: Αγγλικά Γαλλικά (Πολύ καλά) (Βασικές γνώσεις) ΕΠΑΓΓΕΛΜΑΤΙΚΗ ΕΜΠΕΙΡΙΑ: 1992-1994 Εργαστηριακές ασκήσεις Φαρμακευτικής Ανάλυσης στους φοιτητές του Φαρμακευτικού Τμήματος του Πανεπιστημίου Αθηνών. 1994-1997 Εξωτερικός συνεργάτης, Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών, Τμήμα Φαρμακευτικής, Τομέας Φαρμακευτικής Χημείας. 1
05/96 11/96 Τμήμα Έρευνας και Ανάπτυξης (R&D), Φαρμακευτική Βιομηχανία ΕΛΠΕΝ Α.Ε. 12/96-10/00 Φαρμακοποιός στο βαθμό του Επιμελητή Β. Περιφερειακό Γενικό Νοσοκομείο Νοσημάτων Θώρακος Αθηνών, Η ΣΩΤΗΡΙΑ. 01/98-12/00 Εξωτερικός συνεργάτης, Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών, Τμήμα Φαρμακευτικής, Τομέας Φαρμακευτικής Χημείας. 11/00-09/05 Λέκτορας του Τομέα Φαρμακευτικής Χημείας του Φαρμακευτικού Τμήματος του Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών. 09/05-03/11 Επίκουρη Καθηγήτρια του Τομέα Φαρμακευτικής Χημείας του Φαρμακευτικού Τμήματος του Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών. 04/11-σήμερα Αναπληρώτρια Καθηγήτρια του Τομέα Φαρμακευτικής Χημείας του Φαρμακευτικού Τμήματος του Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών. Ερευνητικά ενδιαφέροντα: Μελέτη και αξιολόγηση νέων πληρωτικών υλικών χρωματογραφικών στηλών με σκοπό την ανάπτυξη νέων χρωματογραφικών τεχνικών για τον ποσοτικό προσδιορισμό ή/και την ταυτοποίηση ενώσεων φαρμακευτικού ενδιαφέροντος. Υγροχρωματογραφία υδρόφιλης αλληλεπίδρασης. Ανάπτυξη και αξιολόγηση νέων μεθόδων LC-ESI/MS, LC-APCI/MS, LC- ESI/QTOF-MS. Μελέτες της χρωματογραφικής συμπεριφοράς ουσιών με την τεχνική της χρωματογραφίας ζεύγους ιόντων. Χρωματογραφία βιομορίων (Πεπτίδια) Μελέτες της κινητικής ενζυμικών αντιδράσεων και της σταθερότητας φαρμακευτικών ουσιών σε συνθήκες επιταχυνόμενης διάσπασης. Ποσοτικοί προσδιορισμοί φαρμακευτικών ουσιών με αντιδράσεις σχηματισμού φθορισμοφόρων παραγώγων. Εκπαιδευτική εμπειρία: 1. Εργαστηριακές ασκήσεις Φαρμακευτικής Ανάλυσης στους τεταρτοετείς φοιτητές του Φαρμακευτικού Τμήματος του Πανεπιστημίου Αθηνών. 2. Συμμετοχή στη διδασκαλία του μαθήματος Φαρμακευτική Ανάλυση ΙΙ στους προπτυχιακούς φοιτητές του Φαρμακευτικού Τμήματος. 3. Συμμετοχή στη διδασκαλία του μαθήματος Προχωρημένη Φαρμακευτική Ανάλυση Ι και ΙΙ στους φοιτητές του Μεταπτυχιακού Προγράμματος Σπουδών του Τομέα Φαρμακευτικής Χημείας. 4. Συμμετοχή στη διδασκαλία του μαθήματος του μαθήματος Κλινική Φαρμακευτική Ανάλυση στους φοιτητές του Μεταπτυχιακού Προγράμματος Σπουδών του Τομέα Φαρμακευτικής Χημείας. 2
ΚΡΙΤΗΣ ΕΡΕΥΝΗΤΙΚΩΝ ΠΕΡΙΟΔΙΚΩΝ Analytica Chimica Acta, Journal of Chromatography Α, Journal of Chromatography B 2005-σήμερα, Talanta, International Journal of Mass Spectrometry, Journal of Pharmaceutical and Biomedical Analysis, Journal of Mass Spectrometry, Rapid Communication in Mass Spectrometry, Chromatographia. Μέλος συντακτικής επιτροπής: 1. Chromatographic Research International, webpage: http://www.sage-hindawi.com/53026925.html 2. Φαρμακευτική ΜΕΛΟΣ ΕΝΩΣΕΩΝ ΚΑΙ ΕΠΙΤΡΟΠΩΝ Μέλος της Πανελλήνιας Ένωσης Φαρμακοποιών, του Διοικητικού Συμβουλίου της Ε.Φ.Ε., της Ελληνικής Εταιρίας Φαρμακοχημείας, της Ελληνικής Ένωσης Φασματομετρίας Μαζών και της American Society of Mass Spectrometry Μέλος επιτροπής ΕΣΥΔ για τον έλεγχο αναλυτικών εργαστηρίων ΣΕΜΙΝΑΡΙΑ 1. Advanced Euro-HPLC training course and workshop, Πανεπιστήμιο Πατρών, Τμήμα Χημείας, 7-10 Απριλίου 1992. 2. European Training in Microseparation Techniques (ECOSEP 1), 14-17 Μαϊου 1998, Πάτρα. 3. Επιθεωρήσεις συστημάτων ποιότητας κατά τη σειρά προτύπων ISO-9000 και λήψη πτυχίου επιθεωρητή συστημάτων ποιότητας κατόπιν εξετάσεων. Φορέας εκπαίδευσης : TUV Hellas (RWTUV) AE., 6-10 Μαΐου 2004. 4. API 3000 & Analyst Software: sample introduction, TurboIonSpray (ESI), Heated Nrbulizer (APCI), Chemisry of ionisation, Gurtain Gas interface, Vacuum Interface, Ion path and quadrupole theory, Single MS and MS-MS operation, vacuum system and detector, security configuration, hardware profiles, report formats, calibration of the instrument, auto and manual tuning, source optimization, build acquisition methods, build acquisition batches, qualitative data processing, quantitative data analysis. 23-25 Νοεμβρίου 2004, Darmstadt, Germany. Παρουσιάσεις σε συνέδρια: 1. Second - order derivative spectrophotometric determination of naproxen in the presence of it's metabolite in human plasma.i. Panderi, M. Parissi-Poulou. XXVII Colloquium Spectroscopicum Internationale. York-United Kingdom, June 29th -July 4th 1993. 2. Determination of clopamide and pindolol combination in tablets by HPLC. I. Panderi, P. Papadopoulos, M. Parissi-Poulou 7th Panhellenic Meeting of Pharmacists Athens-Greece, 11-13th June 1994. 3. Partitioning behaviour of â-blocker type benzoxazinone derivatives in different chromatographic and octanol-water systems. A. Tsantili- Kakoulidou, I. Panderi, Ch. Angelopoulos, M. Kazanis, A. Vavayannis. Symposium on "Lipophilicity in Drug Research and Toxicology", Lausanne, Switzerland, March 21-25, 1995. 3
4. Method for the prediction of apparent partition coefficient from structure: I. Theoretical background. F. Csizmadia, F. Darvas, A. Tsantili-Kakoulidou, I. Panderi. Symposium on "Lipophilicity in Drug Research and Toxicology", Lausanne, Switzerland, March 21-25, 1995. 5. Method for the prediction of apparent partition coefficient from structure: II. Test results. A. Tsantili-Kakoulidou, I. Panderi, F. Czizmadia, F. Darvas. Symposium on "Lipophilicity in Drug Research and Toxicology", Lausanne, Switzerland, March 21-25, 1995. 6. Prediction of apparent partion coefficient using PrologD program. A. Tsantili- Kakoulidou, I. Panderi, Czizmadia F., Darvas F. 7th Panhellenic Sumposium of Pharmacochemistry, Athens-Greece, 17-18 November 1995. 7. Method for the prediction of distribution coefficients from structure. Comparison between predicted and experimental data for various drugs. A. Tsantili- Kakoulidou, I. Panderi, S. Piperaki, F. Csizmadia, F.Darvas. 6th European Congress of Biopharmaceutic and Pharmacokinetics, Athens, April 22-23, 1996. 8. Prediction of distribution coefficients from structure. The influence of ion pair formation as reflected in experimental and calculated values. A. Tsantili-Kakoulidou, S. Piperaki, I. Panderi, F. Csizmadia, F.Darvas. 11th European Symposium on Quantitative Structure-Activity Relationships: Computer-Assisted Lead Finding and Optimisation. Lausanne, Switzerland, September 1-6, 1996. 9. Comparative kinetic study on the degradation of prazepam by high-performance liquid chromatography and fourth-order derivative spectrophotometry. E. Archontaki, I. Panderi, E. Gikas, D. Kolovos, M. Parissi-Poulou. EuroAnalysis, Bologna, Italy, September 1-7, 1996. 10. Determination of piroxicam and 5-OH-piroxicam in human plasma by derivative UV-Vis spectrophotometry. I. Panderi, A. Klopas, M. Parissi-Poulou.8th Panhellenic Meeting of Paharmacist, Athens-Greece, 5-7 October 1996. 11. Lipophilicity assesment by means of chromatographic techniques and comparison with calculated logp values for a series of substituted coumarins with antioxidant activity. D. Vrakas, I. Panderi, A. Tsantili-Kakoulidou, D. Hajipavlou-Litina. 6th Conference in Advanced Medicinal Chemistry, Thessaloniki, Greece, 28-29 May 1999. 12. Partitioning behavior in octanol-water and reversed-phase chromatographic systems for a series of substituted coumarins with antioxidant activity. Prediction profiles for various calculation systems D. Vrakas, I. Panderi, A. Tsantili-Kakoulidou, D. Hadjipavlou-Litina. Lipophilicity in Drug Disposition (logp 2000). Lausanne 2000. 13. Multivariate data analysis of the antioxidant activity of a series of substituted coumarins, D. Vrakas, I. Panderi, A. Tsantili-Kakoulidou, D. Hadjipavlou-Litina 13th European Symposium on Quantitative Structure-Activity Relationships, Rational Approaches to Drug Design, 27 August-1 September 2000, Düsseldorf 2000. Development of a fluorescence derivatization high performance liquid chromatographic method for the determination of valproic acid in human plasma. S. Rompotis, M. Parissi-Poulou, E. Gikas, I. Panderi 10th Panhellenic Meeting of Pharmacists, Athens-Greece, 27-29 April 2001. 14. Determination of the carboxylic acid metabolite of clopidogrel in human plasma by liquid chromatography mass spectrometry. A. Mitakos, I. Panderi. 3rd Aegean Analytical Chemistry Day, 27 September-2 October, Polychnitos-Mytilini 2002. 4
15. Determination of dexamethasone in animal blood using liquid chromatography electrospray-ionization mass spectrometry. I. Panderi, A. Gerakis, V. Zonaras, L. Athanasiou, M. Kazanis. 3rd International Conference Instrumental Methods of Analysis Modern Trends and Applications, 23-27 September 2003, Thessaloniki, Greece. 16. Development and validation of a liquid chromatographic/ electrospray ionization mass spectrometric method for the determination of benazepril, benazeprilat and hydrochlorothiazide in human plasma. A. Vonaparti, M. Kazanis, I. Panderi, 4rd International Conference Instrumental Methods of Analysis Modern Trends and Applications, 2-6 October 2005, Heraklion-Crete, Greece. 17. Development and validation of a reversed-phase ion-pair liquid chromatography method for the determination of magnesium ascorbyl phosphate and melatonin in cosmetic creams. A. Varvaresou, E. Tsirivas, K. Iakovou, E. Gikas, Z. Papathomas, A. Vonaparti, I. Panderi. 4rd International Conference Instrumental Methods of Analysis Modern Trends and Applications, 2-6 October 2005, Heraklion-Crete, Greece. 18. Direct analysis of hydrocortisone in horse urine by liquid chromatography ion trap mass spectrometry and liquid chromatography time of flight mass spectrometry. A. Vonaparti, E. Lyris, I. Panderi, C.G.Georgakopoulos. 5th International Conference Instrumental Methods of Analysis Modern Trends and Applications, 30 September- 4 October 2007, Rio-Patra, Greece. 19. Development of an HPLC methodology for the determination of nateglinide with a coumarinic fluorescent reagent. D. Malli, E. Gikas, Κ. Daniilides, A. Vavayannis, M. Kazanis, I. Panderi. 13th Panhellenic Meeting of Paharmacist, Athens-Greece, 12-15 May 2007. 20. Direct Injection LC/ESI-TOF MS Horse Urine Analysis for the Quantification and Identification of Theobromine. Ariadni Vonaparti, Emmanuil Lyris, Irene Panderi, Costas G. Georgakopoulos. 13ο Panhellenic Sumposium of Pharmacochemistry, Athens-Greece, 14 15 March 2008 21. New approaches in Doping control Analysis, Irene Panderi 8 th Panhellenic Meeting of Pharmacy students, 2 nd International Forum of young Doctors, Pharmacy students & young Pharmacists, Athens, Greece, 9-11 May 2008. (Invited speech) 22. Selective and rapid liquid chromatography/ positive-ion electrospray ionization mass spectrometry method for the quantification of methotrexate, folinic acid and folic acid in human serum. P. Koufopantelis, S. Georgakakou, A. Margeli, I. Panderi. 7th Joint Meeting of AFERP, ASP, GA, PSE & SIF, 3-6 August 2008, Athens, Greece. 23. A graphitized carbon HPLC method for the quantification of paracetamol, chlorpheniramine and pseudoephedrine in pharmaceutical formulations. E. Kalogria, M. Koupparis, I. Panderi, 6th International Conference Instrumental Methods of Analysis Modern Trends and Applications,, Athens, Greece, 4-8 October 2009 23.Monitoring Tenoxicam photodegradation pathways by a specific HPLC method: Identification of new photodegradation products by mass spectrometry. A. Voulgari, I. Panderi, E. Antoniadou-Vyza, 6th International Conference Instrumental Methods of Analysis Modern Trends and Applications,, Athens, Greece, 4-8 October 2009 24. Doping control analysis of 3-methoxytyramine in horse urine by hydrophilic interaction liquid chromatography-quadrupole/time-of-flight mass spectrometry. A. Vonaparti, E. Lyris, I.Panderi, M. Koupparis, C. Georgakopoulos, 6th International 5
Conference Instrumental Methods of Analysis Modern Trends and Applications, Athens, Greece, 4-8 October 2009. 25. Direct injection analysis of salicylic acid in horse urine by rapid resolution liquid chromatography-quadrupole/time-of-flight mass spectrometry, A. Vonaparti, E. Lyris, I.Panderi, M. Koupparis, C. Georgakopoulos, 6th International Conference Instrumental Methods of Analysis Modern Trends and Applications,, Athens, Greece, 4-8 October 2009 26. A screening method for the simultaneous detection of multi-class prohibited substances in athlete s urine by LC/TOF-MS for doping control, A. Vonaparti, E. Lyris, Y.S. Angelis, I. Panderi, M. Koupparis, C. Georgakopoulos, 6th International Conference Instrumental Methods of Analysis Modern Trends and Applications,, Athens, Greece, 4-8 October 2009. 27. Hydrophilic interaction liquid chromatography /positive ion electrospray ionization mass spectrometry method for the quantification of perindopril and its main metabolite in human plasma. S. Georgakakou, M. Kazanis, I. Panderi, 6th International Conference Instrumental Methods of Analysis Modern Trends and Applications, Athens, Greece, 4-8 October 2009. ΔΗΜΟΣΙΕΥΣΕΙΣ 49 Δημοσιεύσεις, Citations=584 (self citations excluded), h-index=13, website: www.scopus.com 1. Determination of captopril and captopril-hydrochlorothiazide in tablets by derivative UV spectrophotometry. I. Panderi, M. Parissi-Poulou. Int. J. Pharm., 86, 199-106, 1992. (IF 2010 2.962) 2. Determination of clopamide - pindolol combination in tablets by fourth-order derivative UV spectrophotometry. Ι. Panderi, M. Parissi-Poulou Int. J. Pharm., 99, 327-331, 1993. (IF 2010 2.962) 3. Simultaneous determination of clopamide-pindolol combination in tablets by zero-crossing derivative spectrophotometry. Panderi and M. Parissi-Poulou J. Pharm. and Biomed. Anal., 12(2), 151-156, 1994. (IF 2010 2.453) http://www.ncbi.nlm.nih.gov/pubmed/8003540 4. Second-order derivative spectrophotometric determination of naproxen in the presence of it's metabolite in human plasma. I. Panderi and M. Parissi-Poulou. Analyst, 119, 697-701, 1994. (IF 2010 3.272) http://www.ncbi.nlm.nih.gov/pubmed/8024123 5. Lipophilicity studies on a-blocker type Benzoxazinone derivatives in different Chromatographic and Octanol-Water systems. Panderi I., Tsantili-Kakoulidou A., Angelopoulos Ch., Kazanis M., A.Vavayannis Il Farmaco, 52, 167-172, 1997. 6. Prediction of Distribution Coefficient from structure: 1. Estimation Method. Csizmadia, F., Darvas, F., Tsantili-Kakoulidou, A., Panderi I. J. Pharm. Sci. 86, 865-871, 1997. (IF 2010 2.906) http://www.ncbi.nlm.nih.gov/pubmed/9232530 7. Prediction of Distribution Coefficient from structure: 2. Validation of PrologD, an Expert System. Tsantili-Kakoulidou, A., Panderi, I., Csizmadia, F., Darvas, F. J. Pharm. Sci., 86, 1173-1179, 1997. (IF 2010 2.906) http://www.ncbi.nlm.nih.gov/pubmed/9344176 6
8. Prediction of Distribution Coefficients from sructure. The Influence of Ion Pair Formation as reflected in Experimental and Calculated Values. Tsantili-Kakoulidou A., Piperaki S., Panderi I., Ferenc Csizmadia and Ferenc Darvas. Quant. Struct.-Act. Relat. Journal,16, 315-316, 1997. (IF 2010 3.027) http://www.ncbi.nlm.nih.gov/pubmed/10716058 9. Acidic Hydrolysis of Bromazepam studied by High-Performance Liquid Chromatography. Isolation and Identification of Degradation Products. I. Panteri, H. Archontaki, E. Gikas and M. Parissi-Poulou. J. Pharm. and Biomed. Analysis 17, 327-335, 1998. (IF 2010 2.453) http://www.ncbi.nlm.nih.gov/pubmed/9638586 10. Kinetic Study on the Degradation of Prazepam in Acidic Aqueous Solutions by High Performance Liquid Chromatography and Fourth-Order Derivative. H. A. Archontaki, I. E. Panteri, E. E. Gikas, and M. Parissi-Poulou J. Pharm. Biomed. Anal.17, 739-750, 1998. (IF 2010 2.453) http://www.ncbi.nlm.nih.gov/pubmed/9682158 11. Kinetics and Mechanism of Acidic Hydrolysis of Nordazepam studied by High- Performance Liquid Chromatography and Fourth-Order Derivative Ultraviolet Spectrophotometry. H. A. Archontaki, E. Ε. Gikas, I. E. Panteri and P. Ovezikoglou Int. J. Pharmaceutics, 167, 69-81, 1998. (IF 2010 2.962) 12. Determination of piroxicam and 5-hydroxypiroxicam in human plasma by zerocrossing first derivative spectrophotometry. Klopas A., Panderi I., and M. Parissi- Poulou. J. Pharm. Biomed. Anal. 17, 515-524, 1998. (IF 2010 2.453) http://www.ncbi.nlm.nih.gov/pubmed/9656164 13. Kinetic investigation on the degradation of lorazepam in acidic aqueous solution by high-performance liquid chromatography. I. Panderi, H.Archontaki, E.Gikas, and M. Parissi-Poulou. J. Liq. Chromatogr., 21(12), 1783-1795, 1998. (IF 2010 0.998) 14. Prediction of Distribution Coefficients from structure. Comparison of calculated and experimental data for various drugs. Tsantili-Kakoulidou A., Panderi I., Piperaki S., Csizmadia F., and Darvas F. Eur. J. Drug Metab. and Pharm., 24(3), 205-212, 1999. http://www.ncbi.nlm.nih.gov/pubmed/10716058 15. Kinetic investigation on the degradation of lorazepam by a zero-crossing firstorder derivative UV-spectrophotometric technique. H. A. Archontaki, K. Atamian, I. E. Panderi and E. Ε. Gikas. Ταlanta, 48, 685-693, 1999. (IF 2010 3.290) http://www.ncbi.nlm.nih.gov/pubmed/18967509 16. Determination of hyoscine n-butyl bromide, lidocaine hydrochloride and paracetamol in injection forms using solid-phase extraction, high-performance liquid chromatography and UV-Vis spectrophotometry M. Parissi-Poulou, I. Panderi J. Liq. Chromatogr. 22(7), 1055-1068, 1999. (IF 2010 =0.998) 17. Simultaneous determination of benazepril hydrochloride and hydrochlorothiazide in tablets by second-order derivative spectrophotometry. I. Panderi, J. Pharm. Biomed. Anal. 21, 257-265, 1999 (IF 2010 2.453) http://www.ncbi.nlm.nih.gov/pubmed/10703980 18. Determination of benazepril hydrochloride and hydrochlorothiazide in tablets by micro-bore high-performance liquid chromatography. I. Panderi and M. Parissi- Poulou, J. Pharm. Biomed. Anal. 21, 1017-1024, 1999. (IF 2010 2.453) http://www.ncbi.nlm.nih.gov/pubmed/10703970 7
19. Kinetics of the acidic and enzymatic hydrolysis of benazepril hydrochloride studied by LC. M. Gana, I. Panderi, M. Parissi-Poulou, and A. Tsantili-Kakoulidou J. Pharm. Biomed. Anal. 27, 107-116, 2002. (IF 2010 2.453) http://www.ncbi.nlm.nih.gov/pubmed/11682216 20. Development and validation of a reversed-phase HPLC method for the determination of pindolol and clopamide in tablets. P. Papadopoulos, M. Parissi- Poulou and I. Panderi, J. Liq. Chromatogr. & Relat. Technol. 25, 125-136, 2002. (IF 2010 =0.998) 21. A new Fluorogenic Reagent for labeling carboxylic acids in HPLC, E. Gikas, M. Derventi, I. Panderi, A. Vavayannis, M. Kazanis and M. Parissi-Poulou, J. Liq. Chromatogr. & Relat. Technol. 25(3), 381-395, 2002. (IF 2010 =0.998) 22. Determination of Valproic Acid in Human Plasma by HPLC with Fluorescence detection. S. Rompotis, M. Parissi-Poulou, E. Gikas, M. Kazanis, A. Vavayannis, and I. Panderi J. Liq. Chromatogr. 25(18), 2833-2847, 2002. (IF 2010 =0.998) 23. A validated high-performance liquid chromatographic method for the determination of clopidogrel in pharmaceutical preparations, A. Mitakos and I. Panderi, J. Pharm. Biomed. Anal. 28(3-4),431-438, 2002. (IF 2010 2.453) http://www.ncbi.nlm.nih.gov/pubmed/12008121 24. Determination of the carboxylic acid metabolite of clopidogrel in human plasma by liquid chromatography electrospray ionization mass spectrometry, A. Mitakos, I. Panderi Anal. Chim. Acta, 505(1), 107-114, 2004. (IF 2010 =3.737) 25. Development and validation of a liquid chromatography-electrospray ionization mass spectrometric method for the determination of dexamethasone in sheep plasma. I. Panderi, A. Gerakis, V. Zonaras, L. Athanasiou, M. Kazanis., Anal. Chim. Acta, 504(2), 299-306, 2004. (IF 2010 =3.737) 26. Development and validation of a high-performance liquid chromatographic method for the determination of buspirone in pharmaceutical preparations. M. Zaxariou, I. Panderi J. Pharm. Biomed. Anal., 35(1), 41-50, 2004. (IF 2010 =2.453) http://www.ncbi.nlm.nih.gov/pubmed/15030878 27. Α Validated liquid chromatography-tandem mass spectrometry method for the determination of mirtazapine and demethylmirtazapine in human plasma: application to a pharmacokinetic study. C. Pistos, M. Koutsopoulou, I. Panderi Anal. Chim. Acta 514 (1), 15-26, 2004. (IF 2010 =3.737) 28. Liquid chromatography-positive ion electrospray mass spectrometry method for the quantification of citalopram in human plasma. C. Pistos, J. Atta-Politou, I. Panderi J. Chromatogr. B., 810 (2), 235-244, 2004. (IF 2010 =2.777) http://www.ncbi.nlm.nih.gov/pubmed/15380720 29. In Vitro Percutaneous Absorption of Pine Bark Extract (Pycnogenol) in Human Skin. V. Sarikaki., M. Rallis, H. Tonojo, I. Panteri, Y. Dotsikas, Y.L. Loukas, G. Papaioannou, C. Demetzos, S. Weber, H. Moini, H.I. Maibach, and L. Packer J. Toxicology, Cutaneous and Occular Toxicology, 23 (3), 149-158, 2004. 30. Investigation of the relationships between logp and various chromatographic indices for a series of substituted coumarins. Evaluation of their similarity/dissimilarity using multivariate statistics. D. Vrakas, I. Panderi, D. Hadjipavlou-Litina, A.Tsantili- Kakoulidou Quant. Struct.-Act. Relat. Journal. 24 (2), 254-260, 2004. (IF 2010 =3.027) 31. Development and validation of a liquid chromatographic/electrospray ionization mass spectrometric method for the quantitation of prazepam and its main 8
metabolites in human plasma P. Valavani, J. Atta-Politou, I. Panderi J. Mass Spectrom. 40(4), 516-526, 2005. (IF 2010 =3.411) http://www.ncbi.nlm.nih.gov/pubmed/15712230 32. Liquid chromatographic tandem mass spectrometric determination of trandolapril in human plasma. C. Pistos, M. Koutsopoulou, I. Panderi, Anal. Chim. Acta, 540 (2), 375-382, 2005. (IF 2010 =3.737) 33. Improved liquid chromatographic tandem mass spectrometric determination and pharmacokinetic study of glimepiride in human plasma. C. Pistos, M. Koutsopoulou, I. Panderi Biomedical Chromatography. 19 (5), 394-401, 2005. (IF 2010 =1.639) http://www.ncbi.nlm.nih.gov/pubmed/15651098 34. Development and validation of a liquid chromatographic/ electrospray ionization mass spectrometric method for the determination of benazepril, benazeprilat and hydrochlorothiazide in human plasma. Vonaparti A., Kazanis M., Panderi I. J. Mass Spectrometry 41, 593-605, 2006. (IF 2010 =3.411) http://www.ncbi.nlm.nih.gov/pubmed/16541390 35. Development and validation of a reversed-phase ion-pair liquid chromatography method for the determination of magnesium ascorbyl phosphate and melatonin in cosmetic creams. A. Varvaresou, E. Tsirivas, K. Iakovou, E. Gikas, Z. Papathomas, A. Vonaparti, I. Panderi. Anal. Chim. Acta, 573-574, 284-290, 2006. (IF 2010 =3.757) http://www.ncbi.nlm.nih.gov/pubmed/17723535 36. Ultra performance liquid chromatography-tandem mass spectrometry method for the determination of lercanidipine in human plasma. M. Kalovidouris, S. Michalea, N. Robola, M. Koutsopoulou, I. Panderi, Rapid. Commun. Mass Spectrom. 20(19), 2939-2946, 2006. (IF 2010 =2.695) http://www.ncbi.nlm.nih.gov/pubmed/16941725 37. Development and validation of a reversed phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations. D. Kyriakides, I. Panderi, Anal. Chim. Acta, 584(1) 153-159 2007. (IF 2010 =3.757) http://www.ncbi.nlm.nih.gov/pubmed/17386598 38. Determination of nateglinide in human plasma by high-performance liquid chromatography with pre-column derivatization using a coumarin-type fluorescent reagent. D. Malli, E. Gikas, A. Vavayannis, M. Kazanis, Κ. Daniilides, I. Panderi. Anal. Chim. Acta 599 (1) 143-150. (IF 2010 =3.757) http://www.ncbi.nlm.nih.gov/pubmed/17765074 39. Preventative doping control analysis: liquid and gas chromatography time-offlight mass spectrometry for detection of designer steroids. C. Georgakopoulos, A. Vonaparti, M. Stamou, P. Kiousi, E. Lyris, Y. Angelis, G. Tsoupras, B. Wuest, M. Nielen, I. Panderi, M. Koupparis, Rapid Commun. Mass Spectrom. 21, 2007, 1 8. (IF 2010 =2.695) http://www.ncbi.nlm.nih.gov/pubmed/17610244 40. Selective and rapid liquid chromatography/negative-ion electrospray ionization mass spectrometry method for the quantification of valacyclovir and its metabolite in human plasma. Kasiari M., Gikas E., Georgakakou S., Kazanis, Panderi I., J. Chromatogr. B, 864 (1-2), 78-86, 2008. (IF 2010 =2.777) http://www.ncbi.nlm.nih.gov/pubmed/18295558 41. An Improved Narrow-Bore LC Method for Quantification of Alfuzosin in Pharmaceutical Formulations. Aerakis N., Vonaparti A., Panderi I., Chromatographia, 67 (9-10), 701-707, 2008. (IF 2010 =1.098) 9
42. Direct injection LC/ESI-MS horse urine analysis for the quantification and identification of threshold substances for doping control. I. Determination of hydrocortisone. Vonaparti A., Lyris E., Panderi I., Koupparis M., Georgakopoulos C., J. Mass Spectrom., 43, 1255-1264, 2008. (IF 2010 =3.757) http://www.ncbi.nlm.nih.gov/pubmed/18407581 43. Direct injection liquid chromatography/electrospray ionization mass spectrometric horse urine analysis for the quantification and confirmation of threshold substances for doping control. II. Determination of theobromine. A. Vonaparti, E. Lyris, I. Panderi, M. Koupparis, C. Georgakopoulos Rapid Commun. Mass Spectrom. 23, 1020-1027, 2009. (IF 2010 =2.695) http://www.ncbi.nlm.nih.gov/pubmed/19263423 44 Direct injection horse urine analysis for the quantification and confirmation of threshold substances for doping control. III Determination of salicylic acid by liquid chromatography time-of-flight mass spectrometry. A. Vonaparti, E. Lyris, I. Panderi, M. Koupparis, C. Georgakopoulos Anal. Bioanal. Chem. 395, 1403-1410, 2009 (IF 2010 =3.480) http://www.ncbi.nlm.nih.gov/pubmed/19756547 45. Direct injection liquid chromatography/positive ion electrospray ionization mass spectrometric quantification of methotrexate, folinic acid, folic acid and ondansetron in human serum. Koufopantelis P., Georgakakou S., Kazanis M., Giaginis C., Margeli A., Papargiri S., Panderi I., J. Chromatogr. B, 877(30), 3850-3856, 2009 (IF 2010 =2.777) http://www.ncbi.nlm.nih.gov/pubmed/19828383 46. Direct injection horse-urine analysis for the quantification and confirmation of threshold substances for doping control. IV. Determination of 3-methoxytyramine by hydrophilic interaction liquid chromatography/ quadrapole time-of-flight mass spectrometry, A. Vonaparti, E. Lyris, I. Panderi, M. Koupparis, C. Georgakopoulos, Drug Test. Analysis 1, 365-371, 2009 http://www.ncbi.nlm.nih.gov/pubmed/20355216 47. Hydrophilic interaction liquid chromatography /positive ion electrospray ionization mass spectrometry method for the quantification of perindopril and its main metabolite in human plasma, S. Georgakakou, M. Kazanis, I. Panderi, Anal. Bioanal. Chem 397(6):2161-217, 2010 (IF 2010 =3.480) http://www.ncbi.nlm.nih.gov/pubmed/20195579 48. A Porous Graphitized Carbon HPLC Method For The Quantification Of Paracetamol, Pseudoephedrine And Chlorpheniramine In Pharmaceutical Formulations. Kalogria E., Koupparis M., Panderi I., J. AOAC Int., 93(4)1093-1101, 2010 (IF=1.122) http://www.ncbi.nlm.nih.gov/pubmed/20922939 49. Preventive doping control screening analysis of prohibited substances in human urine using rapid resolution liquid chromatography / high resolution time of flight mass spectrometry, Vonaparti A., Lyris E., Angelis Y.S., Panderi I., Koupparis M., Tsantili- Kakoulidou A., Peters R.J.B., Nielen M.W.F., Georgakopoulos C. Rapid Commun. Mass Spectrom. 24 (11), 1595-1609 2010 (IF 2010 =2.695) http://www.ncbi.nlm.nih.gov/pubmed/20486255 10